Palivizumab
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).
NON-FDA APPROVED USES
- Treatment of serious RSV pneumonia in immunocompromised adult patients (limited data).
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).
NON-FDA APPROVED USES
- Treatment of serious RSV pneumonia in immunocompromised adult patients (limited data).
There's more to see -- the rest of this entry is available only to subscribers.